Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00274924. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
ClinicalTrials.gov study NCT01193842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00121199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
B Cell Induction in Pediatric Lung Transplantation
ClinicalTrials.gov study NCT02266888. IPD Sharing: YES. Countries: 1. Publications: 2.
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
ClinicalTrials.gov study NCT00446095. IPD Sharing: NO. Countries: 1. Publications: 1.
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
ClinicalTrials.gov study NCT01200589. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03145064. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
ClinicalTrials.gov study NCT00281918. IPD Sharing: Not stated. Countries: 11. Publications: 11.
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
ClinicalTrials.gov study NCT04464200. IPD Sharing: YES. Countries: 1. Publications: 2.
An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
ClinicalTrials.gov study NCT02413489. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Short-term B-cell Depletion in Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT03853746. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
ClinicalTrials.gov study NCT01165112. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell Transplant
ClinicalTrials.gov study NCT01431209. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
ClinicalTrials.gov study NCT01626352. IPD Sharing: Not stated. Countries: 1. Publications: 23.
Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT02457559. IPD Sharing: NO. Countries: 2. Publications: 5.
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04317313. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation
ClinicalTrials.gov study NCT03456726. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eli
ClinicalTrials.gov study NCT01321541. IPD Sharing: Not stated. Countries: 17. Publications: 2.
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
ClinicalTrials.gov study NCT02659943. IPD Sharing: NO. Countries: 1. Publications: 1.
Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma
ClinicalTrials.gov study NCT01593696. IPD Sharing: NO. Countries: 1. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.